Primary Cutaneous CD4+ Small or Medium T-Cell Lymphoproliferative Disorder With Persistent B-Cell Clone: Clinicopathologic Challenge

被引：0
作者：
Shaker, Nada [1 ]
Phelps, Robert [2 ,3 ]
Niedt, George [2 ,3 ]
Gupta, Neha [4 ]
Sangueza, Omar P. [5 ]
Pradhan, Dinesh [4 ]
机构：
[1] Ohio State Univ, Wexner Med Ctr, Dept Pathol, 410 W,10th Ave, Columbus, OH 43210 USA
[2] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY USA
[3] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY USA
[4] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA
[5] Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol & Dermatol, Med Ctr Blvd, Winston Salem, NC USA
来源：
AMERICAN JOURNAL OF DERMATOPATHOLOGY | 2024年 / 46卷 / 09期
关键词：
TERM-FOLLOW-UP; LYMPHOMA; DIAGNOSIS; MULTICENTER; FEATURES;
D O I：
10.1097/DAD.0000000000002707
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：626 / 628
页数：3
相关论文
共 21 条
  • [1] Clinicopathological and molecular study of primary cutaneous CD4+small/medium-sized pleomorphic T-cell lymphoma
    Alberti-Violetti, Silvia
    Torres-Cabala, Carlos A.
    Talpur, Rakhshandra
    Corti, Laura
    Fanoni, Daniele
    Venegoni, Luigia
    Berti, Emilio
    Duvic, Madeleine
    [J]. JOURNAL OF CUTANEOUS PATHOLOGY, 2016, 43 (12) : 1121 - 1130
  • [2] Prominent Blasts in Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder. A Reconsideration of Diagnostic Criteria
    Bakr, Farrah
    Wain, E. Mary
    Wong, Sharon
    Palmer, Roy
    Robson, Alistair
    [J]. AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2021, 43 (12) : E190 - E196
  • [3] Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder or Primary Cutaneous Marginal Zone B-Cell Lymphoma? Two Distinct Entities With Overlapping Histopathological Features
    Bakr, Farrah
    Wain, E. Mary
    Barlow, Richard
    Robson, Alistair
    [J]. AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2021, 43 (12) : E204 - E212
  • [4] Primary Cutaneous Follicular Helper T-cell Lymphoma A New Subtype of Cutaneous T-cell Lymphoma Reported in a Series of 5 Cases
    Battistella, Maxime
    Beylot-Barry, Marie
    Bachelez, Herve
    Rivet, Jacqueline
    Vergier, Beatrice
    Bagot, Martine
    [J]. ARCHIVES OF DERMATOLOGY, 2012, 148 (07) : 832 - 839
  • [5] Primary and secondary cutaneous CD30+ lymphoproliferative disorders:: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment
    Bekkenk, MW
    Geelen, FAMJ
    Vader, PCV
    Heule, F
    Geerts, ML
    van Vloten, WA
    Meijer, CJLM
    Willemze, R
    [J]. BLOOD, 2000, 95 (12) : 3653 - 3661
  • [6] Beltzung F, 2020, AM J SURG PATHOL, V44, P862, DOI 10.1097/PAS.0000000000001470
  • [7] Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: Diagnosis and management
    Besch-Stokes, Jake G.
    Costello, Collin M.
    Severson, Kevin J.
    Bhullar, Puneet
    Montoya, Jordan
    Butterfield, Richard J.
    DiCaudo, David J.
    Comfere, Nneka
    Sluzevich, Jason
    Rule, William
    Craig, Fiona E.
    Rosenthal, Allison
    Pittelkow, Mark R.
    Mangold, Aaron R.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 86 (05) : 1167 - 1169
  • [8] Multifocal CD4+ Primary Cutaneous Small/Medium Lymphoproliferative Disorder Successfully Treated With Low-Dose Oral Methotrexate: A Case Report
    Dimassi, Ahmad B.
    Howlett, Christopher
    Phua, Chai W.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (06)
  • [9] Primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma: a clonal T-cell lymphoproliferative disorder with indolent behavior
    Grogg, Karen L.
    Jung, Sungmi
    Erickson, Lori A.
    McClure, Rebecca F.
    Dogan, Ahmet
    [J]. MODERN PATHOLOGY, 2008, 21 (06) : 708 - 715
  • [10] Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder-clinical and histopathologic features, differential diagnosis, and treatment
    Gru, Alejandro A.
    Wick, Mark R.
    Eid, Mary
    [J]. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2018, 37 (01) : 39 - 48
123